
A minority of patients with multiple sclerosis (MS) have primary progressive disease, and it has few treatment options.
Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.

A minority of patients with multiple sclerosis (MS) have primary progressive disease, and it has few treatment options.

A formulation of dihydroergotamine (DHE) in a nasal powder form was no different than placebo for relief from pain and annoying symptoms at 2 hours post dose.

To mark the 25th anniversary of the journal, each issue in 2020 will include a special feature: an interview with a thought leader in the world of health care and medicine. The September issue features a conversation with Georges C. Benjamin, MD, executive director of the American Public Health Association.

Researchers wanted to see if children with a certain allele benefitted from receiving montelukast instead of long-acting beta-2 agonist/inhaled corticosteroid therapy.

Pralsetinib (Gavreto), developed by Blueprint Medicines, received accelerated approval. Thermo Fisher Scientific's Oncomine Dx Target Test received premarket approval as a companion diagnostic to identify patients who are candidates for the once-daily oral RET-targeted therapy.

Hepatocellular carcinoma is rising, and so is the need for increased awareness and use of palliative care, say the authors of a recent review.

A review warns against delaying or ignoring the concerns of individuals with chronic pain during the coronavirus disease 2019 (COVID-19) pandemic.

Nineteen bioethicists proposed a 3-phase plan for equitable distribution of a vaccine for coronavirus disease 2019 (COVID-19).

The report explored the use of intravenous lidocaine in a hospital that expanded its use beyond postoperative gastrointestinal surgery.

Two days after the CDC changed its guidance on who should get tested for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), HHS said the move was not politically motivated.

Adherence to multiple sclerosis (MS) therapy is linked with improved clinical outcomes, better quality of life, lower health care costs, and other benefits.

A move by HHS to allow pharmacists to give childhood vaccinations draws criticism from the American Academy of Pediatrics.

New guidelines from the American College of Physicians and the American Academy of Family Physicians are cautioning providers against treating patients with acute pain from musculoskeletal injuries with opioids.

A community oncology practice network and a cancer genomics firm announced an initiative to expand opportunities for real-time precision medicine as well as research participation.

Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).

The thalamus is among the first brain areas to atrophy in multiple sclerosis (MS); this study wanted to know if measuring this loss can predict future disability.

A recent study explored how chronic pain affects occupational status, the distribution of household chores, and marital satisfaction.

High-quality research is needed to generate evidence to back neurofeedback for pain management, a recent review says.

The authors said the findings bring new urgency to efforts by policy makers, school officials, community leaders, and others to educate the public about the link between smoking and coronavirus disease 2019 (COVID-19).

A community-based program helped reduce pain using cognitive behavioral therapy techniques in low-income, primarily Black individuals with coexisting pain and diabetes.

A recent meta-analysis looked at noninvasive vagus nerve stimulation (nVNS), a nonpharmacologic method of acute pain relief for headaches.


Tisagenlecleucel, sold as Kymriah by Novartis, met its primary end point of complete response rate (CRR) in an interim analysis of a phase 2 study for relapsed or refractory follicular lymphoma (FL).

To mark the 25th anniversary of the journal, each issue in 2020 will include an interview with a health care thought leader. The August issue features a conversation with Mandy K. Cohen, MD, MPH, secretary of the North Carolina Department of Health and Human Services.

Among the changes announced this week include the expanded use of telehealth in Medicare, giving payment parity to hospital outpatient surgery centers, simplifying evaluation and management codes, and changing performance measures for accountable care organizations (ACOs).

Understanding the patient point of view can help with treatment decisions as well as gauge the impact of treatment, the authors said.

Occipital pain is linked to migraine, but the 2 conditions are sometimes difficult to separate.

The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.

Using a computational algorithm, researchers at Children's Hospital of Philadelphia analyzed noncoding genetic mutations to discover how they factor into 5 pediatric cancers.

The health burden of comorbid chronic obstructive pulmonary disease (COPD) and asthma is known to be greater than when either condition exists on its own. An upcoming study shows that COPD is linked with greater all-cause mortality and greater risk of mortality in patients with coexisting asthma who also had long-term use of corticosteroids.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
